Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 07, 2022

SELL
$225.82 - $368.51 $777,724 - $1.27 Million
-3,444 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$221.9 - $484.47 $153,776 - $335,737
693 Added 25.19%
3,444 $1.33 Million
Q2 2021

Aug 16, 2021

BUY
$129.91 - $234.98 $357,382 - $646,429
2,751 New
2,751 $647,000
Q2 2020

Aug 14, 2020

SELL
$29.67 - $80.0 $9,850 - $26,560
-332 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$17.78 - $31.58 $5,902 - $10,484
332 New
332 $10,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Claraphi Advisory Network, LLC Portfolio

Follow Claraphi Advisory Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Claraphi Advisory Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Claraphi Advisory Network, LLC with notifications on news.